Literature DB >> 27990583

The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Järve, Estonia.

Annika Johannson1, Sigrid Vorobjov2, Robert Heimer3,4, John F Dovidio5, Anneli Uusküla6.   

Abstract

Disclosure of injecting drug use and its associations with stigma have received very little research attention. This cross-sectional study examined the role of internalized HIV and drug stigma (i.e., self-stigmatization) in the disclosure of injecting drug use among people who inject drugs (PWID) self-reporting as HIV-positive (n = 312) in Kohtla-Järve, Estonia. The internalization of both stigmas was relatively high. On average, PWID disclosed to three disclosure targets out of seven. Disclosure was highest to close friends and health care workers and lowest to employers and casual sex partners. Internalized drug stigma was negatively associated with disclosure to other family members (AOR = 0.48; 95% CI 0.30-0.77) and health care workers (AOR = 0.46; 95% CI 0.25-0.87). Internalized HIV stigma was positively associated with disclosure to health care workers (AOR = 2.26; 95% CI 1.27-4.00). No interaction effect of internalized stigmas on disclosures emerged. We concluded that effects of internalized stigmas on disclosures are few and not uniform.

Entities:  

Keywords:  Disclosure; Estonia; HIV; Injecting drug use; Internalized stigma

Mesh:

Year:  2017        PMID: 27990583     DOI: 10.1007/s10461-016-1647-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  6 in total

1.  Substance Use Stigma and Antiretroviral Therapy Adherence Among a Drug-Using Population Living with HIV.

Authors:  Kristi Lynn Stringer; Phillip Marotta; Elizabeth Baker; Bulent Turan; Mirjam-Colette Kempf; Patricia Drentea; Irena Stepanikova; Janet M Turan
Journal:  AIDS Patient Care STDS       Date:  2019-06       Impact factor: 5.078

2.  Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada.

Authors:  Lindsay A Pearce; Fahmida Homayra; Laura M Dale; Soroush Moallef; Brittany Barker; Alexa Norton; Kanna Hayashi; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2020-07-27

3.  Stigma Related to HIV and Drug Use: Layers, Types, and Relations to Mental Health.

Authors:  Li Li; Chunqing Lin; Nan Feng; Diep Bich Nguyen; Wei Cao; Anh Tuan Le; Anh Tuan Nguyen
Journal:  AIDS Behav       Date:  2020-08

Review 4.  A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries.

Authors:  Jeremy C Kane; Melissa A Elafros; Sarah M Murray; Ellen M H Mitchell; Jura L Augustinavicius; Sara Causevic; Stefan D Baral
Journal:  BMC Med       Date:  2019-02-15       Impact factor: 8.775

Review 5.  Optimizing HIV prevention and treatment outcomes for persons with substance use in Central Asia: what will it take?

Authors:  Anna P Deryabina; Wafaa M El-Sadr
Journal:  Curr Opin HIV AIDS       Date:  2019-09       Impact factor: 4.283

6.  Testing Mindful Awareness as a Moderator in the Association Between HIV-Related Stress and Drug and Alcohol Use Problems Among People Living with HIV.

Authors:  K Marie Sizemore; Steven Samrock; Shannon Gray; David Marcotte; H Jonathon Rendina
Journal:  Mindfulness (N Y)       Date:  2020-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.